Financial Wire

Persian Gulf Outlook Lifts Asian Stock Markets

-- Asian stock markets rallied on Tuesday after US President Donald Trump indicated that Tehran-Washington negotiations to end Persian Gulf hostilities might resume, and as relative calm prevailed in the Strait of Hormuz.

Hong Kong, Shanghai and Tokyo finished in the green, as did other regional exchanges, led by 2.7% rise on Seoul's KOSPI index. Exchanges in Bangkok and Mumbai were closed on holiday.

In Japan, the Nikkei 225 opened higher and rose to the close, finishing up 2.4% on Middle East outlooks and after US military ships navigated the Strait of Hormuz without incident.

The benchmark Nikkei 225 rose 1,374.62 to 57,877.39, as gaining issues outnumbered losers 136 to 87.

Leading the upside was tech-financiers SoftBank, up 12.7%, while property-concern Haseko declined 5.7%.

In Hong Kong, the Hang Seng Index opened higher, wobbled, but closed up 0.8% on strength in property issues.

The broad gauge Hang Seng rose 211.47 to 25,872.32, as gaining issues outnumbered losers 61 to 29. The Hang Seng TECH Index gained 0.6% on the day, while the Mainland Properties Index rallied 3.2%.

Leading the upside was toymaker Pop Mart International, gaining 6.5%, while Xinyi Solar declined 3.4%.

On the mainland, the Shanghai Composite rose 1% to 4,026.63.

In economic news, China's export growth slowed to 2.5% on-year in March, down from 21.8% on-year logged in the first two months of the year, reported the National Bureau of Statistics (NBS).

In contrast, China's imports rose 27.8% on year in March, up from the 19.8% on-year gain recorded in the first two months of the year.

On the other regional exchanges, the Taiwan TWSE inclined 2.4%, the Australian ASX 200 inclined 0.5% and the Singapore Straits Times Index rose 0.5%.

The MSCI All Country Asia Pacific Index rose 1.9% on the day.

Related Articles

Australia

Arcus Biosciences Discontinues Phase 3 Lung Cancer Trial for Futility

Arcus Biosciences (RCUS) said Monday it discontinued its phase 3 STAR-121 study in metastatic non-small cell lung cancer after an Independent Data Monitoring Committee recommended stopping the trial for futility.The study, conducted in collaboration with Gilead Sciences (GILD), evaluated domvanalimab plus zimberelimab and chemotherapy versus pembrolizumab plus chemotherapy as a first-line treatment, the company said.The decision followed a pre-planned futility analysis indicating the treatment was unlikely to meet its primary endpoint.Shares of Arcus Biosciences were down 5% in Monday trading.Price: $23.05, Change: $-1.20, Percent Change: -4.95%

$GILD$RCUS
Australia

Sila Realty Trust to be Taken Private by Blue Owl Affiliates in $2.4 Billion Deal

Sila Realty Trust (SILA) agreed to be acquired and taken private by certain affiliates of Blue Owl Capital's (OWL) real estate unit in an all-cash deal worth roughly $2.4 billion.Shareholders of net lease real estate investment trust Sila will receive $30.38 per share, representing a 19% premium to the stock's closing price on Friday, the companies said Monday.The transaction, which requires approval from Sila's shareholders, is anticipated to complete in the second or third quarter of this year. Upon completion, the company will be delisted from the New York Stock Exchange."The consummation of this transaction will provide significant and immediate realized benefit to our shareholders," Sila Chief Executive Michael Seton said in a statement.Shares of Sila were up 19% in Monday trade. Asset manager Blue Owl rose 1%.Sila, which is focused on investing in healthcare facilities, said its portfolio comprised 137 real estate properties and three undeveloped land parcels in the US as of end-March. Data on its website showed its portfolio includes 86 medical outpatient buildings, 25 inpatient rehabilitation facilities, and 26 surgical and specialty facilities."This transaction provides us with a compelling opportunity to acquire a scaled portfolio with durable cash flows and attractive long-term growth characteristics, while further expanding Blue Owl managed funds' exposure to an asset class and sector we view as both resilient and essential given its critical role in both society and the economy," Marc Zahr, co-president and global head of real assets at Blue Owl, said.In February, Sila reported fourth-quarter adjusted funds from operations of $0.55 per share, up from $0.54 a year ago. Revenue rose to $50.7 million from $46.5 million.Sila plans to pay up to two regular quarterly dividends ahead of deal completion.Price: $30.44, Change: $+4.90, Percent Change: +19.19%

$OWL$SILA
Australia

Carnival Shareholders Approve Single Company Structure, Redomiciliation

Carnival (CCL, CUK) said Monday that majority of its shareholders approved the proposal to simplify its dual-listed structure into a single company and the redomiciliation of Carnival Corporation to Bermuda from Panama.The company said it expects the proposed changes to become effective on May 7.Price: $28.69, Change: $-0.53, Percent Change: -1.81%

$CCL$CUK